Utrecht, The Netherlands-based ViCentra initially closed its Series D in September, bringing in $85 million. The now-closed extension to the financing brings the total raised to $98 million. CEO Tom Arnold explained the company’s plans for a big commercial push with the funds in an interview with Drug Delivery Business News after the initial closing.
ViCentra said the additional funding follows “a strong year of commercial and operational progress.” It includes new capital from ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech. Existing investor Innovation Industries also took part in the second closing.
The company intends to use funds to scale manufacturing and deepen execution in Germany, the Netherlands and France. It also hopes to accelerate preparations to bring its next-generation Kaleido insulin patch pump to the U.S. market. The company hopes to enter a hot patch pump market, led by Insulet, with potential competitors, like Medtronic/MiniMed, Beta Bionics and Tandem Diabetes Care, are developing their own patch pumps. PharmaSens and SiBionics also recently unveiled their own entry, an all-in-one device, too.
Kaleido, described by the company as the smallest, lightest and most precise insulin patch pump in its class, offers premium materials and customizable aluminum shells in 10 color options to deliver the feel of personal technology rather than a traditional medical device. It integrates with Diabeloop’s self-learning automated insulin delivery algorithm and Dexcom’s leading continuous glucose monitors (CGMs).
“The past year has been transformative for ViCentra,” Arnold said in a news release. “This latest funding enables us to further scale our manufacturing capabilities, strengthen our commercial presence and support in Germany, the Netherlands, and France, and ensures that we remain on course for our planned U.S. market access. Our goal for 2026 is clear: convert our current high demand into satisfied users through uncompromising quality and performance and nearly triple our European user base by the end of 2026.”
